Top Story

Cell therapy amid COVID-19: New anxieties and lessons learned

Cell Therapy Next, May

Regimen extends PFS in relapsed multiple myeloma

May 19, 2020
The addition of isatuximab-irfc to carfilzomib and dexamethasone significantly prolonged PFS among patients with relapsed multiple myeloma, according to topline data…
Meeting NewsPerspective

Videoconference intervention eases anxiety, distress among distance caregivers of patients with cancer

May 14, 2020
Distance caregivers of patients with cancer reported significant reductions in anxiety and distress after completing a series of coaching sessions via videoconference…
FDA News

FDA delays application for investigational CAR-T for advanced multiple myeloma

May 13, 2020
The FDA has issued a refusal to file letter regarding the biologics license application of the investigational chimeric antigen receptor T-cell therapy idecabtagene…
More Headlines »

Picking a PI in MM: Asking & Answering the W5

Provided by Integrity Continuing Education, Inc.
Supported by an educational grant from Takeda Oncology.

More »
Meeting News

VIDEO: Triplet therapy offers ‘new option’ for multiple myeloma

December 16, 2019
More »

2019 Texas Oncology Clinical Educational Symposium

This activity is supported by educational grants from AbbVie, Inc.; Celgene Corporation; Novartis Pharmaceuticals Corporation; Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc.; Takeda Oncology; and Verastem, Inc..

More »